Atezolizumab by F. Hoffmann-La Roche for Oral Cavity (Mouth) Cancer: Likelihood of Approval

Retrieved on: 2024-06-17 22:09:25

Tags for this article:

Click the tags to see associated articles and topics

Atezolizumab by F. Hoffmann-La Roche for Oral Cavity (Mouth) Cancer: Likelihood of Approval. View article details on hiswai:

Excerpt

Atezolizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Oral Cavity (Mouth) Cancer.

Article found on: www.pharmaceutical-technology.com